MedPath

BELSOMRA

BELSOMRA

Discontinued
DIN Number

02483521

Drug Class

Human

Market Date

Apr 18, 2019

Company
HC

Merck Canada Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02483521
AIG Number0160930003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N05CJ01 SUVOREXANT
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:24.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

SUVOREXANTActive
Strength: 15 MG
Monograph: SUVOREXANT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.